FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market
The U.S. Food and Drug Administration approved Eli Lilly's GLP-1 pill, the company said, a major milestone for the Indianapolis-based...
Health care industry
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Texas, Sept. 23, 2025.Antranik Tavitian |...
Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss
A tick (Ixodida) - carrier for several diseases of humans and animals, for exampel the dangerous Lyme disease, babesiosis, anaplasmosis,...
The price of menstrual products is skyrocketing from inflation, tariffs
Always products are displayed on a shelf in a supermarket in Sarajevo, Bosnia and Herzegovina October 29, 2024. Dado Ruvic |...
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
Eli Lilly on Thursday said its next-generation obesity drug retatrutide cleared its first late-stage trial on Type 2 diabetes patients,...
FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025.Kyle Grillot | Bloomberg | Getty...
Inside the booming business of wellness third spaces and membership clubs
A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn't...
FDA vaccine head will step down in April after string of controversial decisions
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human...
Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the U.S., targeting...
How the 'K-shaped' economy is showing up at two big U.S. gyms
Two of the largest U.S. gym operators delivered the same headline in their latest earnings reports: strong growth.But beneath the...
Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,...
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.Shelby...
Trump unveils health-care plan outline as Congress wrestles over Obamacare subsidies
U.S. President Donald Trump, in front of U.S. Secretary of Health and Human Services Robert F. Kennedy Jr., delivers remarks...
Airlines to save big money on fuel as new weight loss pills gain popularity, Wall Street says
Celsopupo | Istock | Getty ImagesWall Street is finding an unexpected beneficiary of America's weight loss boom: airlines.With the first...
CNBC's Becky Quick details daughter's rare disease journey
I've spent the last 25 years in front of the camera here at CNBC, and people have gotten to know...
RFK Jr. announces new nutrition guidelines, pushing more protein and less processed food
Secretary of Health and Human Services Robert F. Kennedy Jr. speaks during the daily briefing in the Brady Briefing Room...
Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs
Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025....
Too early to bet against AI trade, State Street suggests
State Street is reiterating its bullish stance on the artificial intelligence trade despite the Nasdaq's worst week since April.Chief Business...
Novo Nordisk to buy Akero for up to $5.2 billion as new CEO bets on liver drug candidate
A view of the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark,...
Trump, Pfizer to announce agreement to lower drug prices
U.S. President Donald Trump speaks during a press conference in the Roosevelt Room at the White House in Washington, D.C.,...
